Novai
Generated by Meeveem AI
"Pioneering early detection of eye and brain diseases using DARC technology"
Reading
•11 - 50 Employees
•Diagnostics
About Novai
Novai detects eye and brain diseases before symptoms appear. The company's DARC technology identifies sick cells at the earliest stages of glaucoma, macular degeneration, diabetic retinopathy, and neurodegenerative conditions. This enables clinicians to intervene sooner, tailor treatments more precisely, and prevent irreversible vision loss in patients who would otherwise go undiagnosed. The technology combines a patented biomarker with AI to quantify disease activity at the cellular level. For pharmaceutical companies, DARC provides insights into drug mechanisms during preclinical trials. For clinicians, it shortens treatment selection time. For patients, it offers the chance to preserve sight through early intervention.
14
Team Members
2020
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where eye and brain diseases are detected at the cellular level before irreversible damage occurs, enabling everyone to preserve their vision and neurological function through timely, targeted intervention.
Our Mission
At Novai, our mission is to combat blindness and disability by enabling early detection and intervention for eye and brain diseases through DARC technology.